The "A Disintegrin And Metalloprotease" (ADAM) family of sheddases: Physiological and cellular functions

Seminars in Cell and Developmental Biology

Volumn 20, Issue 2, 2009, Pages 126-137

  Reiss, Karina ^a   Saftig, Paul ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

ADAMs; Cancer; Cell adhesion; Inflammation; Signalling

Indexed keywords

ADAM PROTEIN; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; CYTOKINE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LIGAND; PROTEIN ADAM1; PROTEIN ADAM10; PROTEIN ADAM11; PROTEIN ADAM12; PROTEIN ADAM13; PROTEIN ADAM15; PROTEIN ADAM16; PROTEIN ADAM17; PROTEIN ADAM18; PROTEIN ADAM19; PROTEIN ADAM2; PROTEIN ADAM22; PROTEIN ADAM24; PROTEIN ADAM26; PROTEIN ADAM27; PROTEIN ADAM28; PROTEIN ADAM29; PROTEIN ADAM33; PROTEIN ADAM8; PROTEIN ADAM9; PROTEINASE; SHEDDASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANGIOGENESIS; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; HUMAN; KNOCKOUT MOUSE; NEOPLASM; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

MUS;

EID: 63649141727     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2008.11.002     Document Type: Review

References (184)

1. Seals D.F., and Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17 (2003) 7-30
2. Blobel C.P. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6 (2005) 32-43
3. Tousseyn T., Jorissen E., Reiss K., and Hartmann D. (Make) stick and cut loose-disintegrin metalloproteases in development and disease. Birth Defects Res C Embryo Today 78 (2006) 24-46
4. Deuss M., Reiss K., and Hartmann D. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr Alzheimer Res 5 (2008) 187-201
5. Reiss K., Ludwig A., and Saftig P. Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol Ther 111 (2006) 985-1006
6. Huovila A.P., Turner A.J., Pelto-Huikko M., Karkkainen I., and Ortiz R.M. Shedding light on ADAM metalloproteinases. Trends Biochem Sci 30 (2005) 413-422
7. Wolfsberg T.G., Straight P.D., Gerena R.L., Huovila A.P., Primakoff P., Myles D.G., et al. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev Biol 169 (1995) 378-383
8. Puente X.S., and Lopez-Otin C. A genomic analysis of rat proteases and protease inhibitors. Genome Res 14 (2004) 609-622
9. Bode W., Gomis-Ruth F.X., and Stockler W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett 331 (1993) 134-140
10. Pan D., and Rubin G.M. Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90 (1997) 271-280
11. Huang X., Huang P., Robinson M.K., Stern M.J., and Jin Y. UNC-71, a disintegrin and metalloprotease (ADAM) protein, regulates motor axon guidance and sex myoblast migration in C. elegans. Development 130 (2003) 3147-3161
12. Nakamura T., Abe H., Hirata A., and Shimoda C. ADAM family protein Mde10 is essential for development of spore envelopes in the fission yeast Schizosaccharomyces pombe. Eukaryot Cell 3 (2004) 27-39
13. Endres K., Anders A., Kojro E., Gilbert S., Fahrenholz F., and Postina R. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem 270 (2003) 2386-2393
14. Anders A., Gilbert S., Garten W., Postina R., and Fahrenholz F. Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J 15 (2001) 1837-1839
15. Moss M.L., Bomar M., Liu Q., Sage H., Dempsey P., Lenhart P.M., et al. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem 282 (2007) 35712-35721
16. Gonzales P.E., Solomon A., Miller A.B., Leesnitzer M.A., Sagi I., and Milla M.E. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain. J Biol Chem 279 (2004) 31638-31645
17. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., et al. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A 96 (1999) 3922-3927
18. Schlondorff J., Becherer J.D., and Blobel C.P. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J 347 Pt 1 (2000) 131-138
19. Gutwein P., Mechtersheimer S., Riedle S., Stoeck A., Gast D., Joumaa S., et al. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 17 (2003) 292-294
20. Maskos K., Fernandez-Catalan C., Huber R., Bourenkov G.P., Bartunik H., Ellestad G.A., et al. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A 95 (1998) 3408-3412
21. Orth P., Reichert P., Wang W., Prosise W.W., Yarosh-Tomaine T., Hammond G., et al. Crystal structure of the catalytic domain of human ADAM33. J Mol Biol 335 (2004) 129-137
22. White J.M. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15 (2003) 598-606
23. Smith K.M., Gaultier A., Cousin H., Alfandari D., White J.M., and DeSimone D.W. The cysteine-rich domain regulates ADAM protease function in vivo. J Cell Biol 159 (2002) 893-902
24. Reddy P., Slack J.L., Davis R., Cerretti D.P., Kozlosky C.J., Blanton R.A., et al. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275 (2000) 14608-14614
25. Janes P.W., Saha N., Barton W.A., Kolev M.V., Wimmer-Kleikamp S.H., Nievergall E., et al. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123 (2005) 291-304
26. Milla M.E., Leesnitzer M.A., Moss M.L., Clay W.C., Carter H.L., Miller A.B., et al. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J Biol Chem 274 (1999) 30563-30570
27. Iba K., Albrechtsen R., Gilpin B., Frohlich C., Loechel F., Zolkiewska A., et al. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol 149 (2000) 1143-1156
28. Zolkiewska A. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain. Exp Cell Res 252 (1999) 423-431
29. Howard L., Nelson K.K., Maciewicz R.A., and Blobel C.P. Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1. J Biol Chem 274 (1999) 31693-31699
30. Tanaka M., Nanba D., Mori S., Shiba F., Ishiguro H., Yoshino K., et al. ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands. J Biol Chem 279 (2004) 41950-41959
31. Sundberg C., Thodeti C.K., Kveiborg M., Larsson C., Parker P., Albrechtsen R., et al. Regulation of ADAM12 cell-surface expression by protein kinase C epsilon. J Biol Chem 279 (2004) 51601-51611
32. Mori S., Tanaka M., Nanba D., Nishiwaki E., Ishiguro H., Higashiyama S., et al. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J Biol Chem 278 (2003) 46029-46034
33. Wild-Bode C., Fellerer K., Kugler J., Haass C., and Capell A. A basolateral sorting signal directs ADAM10 to adherens junctions and is required for its function in cell migration. J Biol Chem 281 (2006) 23824-23829
34. Marcello E., Gardoni F., Mauceri D., Romorini S., Jeromin A., Epis R., et al. Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci 27 (2007) 1682-1691
35. Peiretti F., Deprez-Beauclair P., Bonardo B., Aubert H., Juhan-Vague I., and Nalbone G. Identification of SAP97 as an intracellular binding partner of TACE. J Cell Sci 116 (2003) 1949-1957
36. Nishimura H., Cho C., Branciforte D.R., Myles D.G., and Primakoff P. Analysis of loss of adhesive function in sperm lacking cyritestin or fertilin beta. Dev Biol 233 (2001) 204-213
37. Brown M.S., Ye J., Rawson R.B., and Goldstein J.L. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100 (2000) 391-398
38. Fluhrer R., and Haass C. Signal peptide peptidases and gamma-secretase: cousins of the same protease family?. Neurodegener Dis 4 (2007) 112-116
39. Hattori M., Osterfield M., and Flanagan J.G. Regulated cleavage of a contact-mediated axon repellent. Science 289 (2000) 1360-1365
40. Maretzky T., Reiss K., Ludwig A., Buchholz J., Scholz F., Proksch E., et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci U S A 102 (2005) 9182-9187
41. Reiss K., Maretzky T., Ludwig A., Tousseyn T., de Strooper B., Hartmann D., et al. ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J 24 (2005) 742-752
42. Reiss K., Maretzky T., Haas I.G., Schulte M., Ludwig A., Frank M., et al. Regulated ADAM10-dependent ectodomain shedding of {gamma}-protocadherin C3 modulates cell-cell adhesion. J Biol Chem 281 (2006) 21735-21744
43. Schulz B., Pruessmeyer J., Maretzky T., Ludwig A., Blobel C.P., Saftig P., et al. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 102 (2008) 1192-1201
44. Marambaud P., Shioi J., Serban G., Georgakopoulos A., Sarner S., Nagy V., et al. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21 (2002) 1948-1956
45. Marambaud P., Wen P.H., Dutt A., Shioi J., Takashima A., Siman R., et al. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114 (2003) 635-645
46. Maretzky T., Scholz F., Koten B., Proksch E., Saftig P., and Reiss K. ADAM10-mediated E-cadherin release is regulated by proinflammatory cytokines and modulates keratinocyte cohesion in eczematous dermatitis. J Invest Dermatol 128 (2008) 1737-1746
47. Junghans D., Haas I.G., and Kemler R. Mammalian cadherins and protocadherins: about cell death, synapses and processing. Curr Opin Cell Biol 17 (2005) 446-452
48. Haas I.G., Frank M., Veron N., and Kemler R. Presenilin-dependent processing and nuclear function of gamma-protocadherins. J Biol Chem 280 (2005) 9313-9319
49. Garton K.J., Gough P.J., and Raines E.W. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol 79 (2006) 1105-1116
50. Garton K.J., Gough P.J., Philalay J., Wille P.T., Blobel C.P., Whitehead R.H., et al. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 278 (2003) 37459-37464
51. Tsakadze N.L., Sithu S.D., Sen U., English W.R., Murphy G., and D'Souza S.E. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J Biol Chem 281 (2006) 3157-3164
52. Abel S., Hundhausen C., Mentlein R., Schulte A., Berkhout T.A., Broadway N., et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172 (2004) 6362-6372
53. Ludwig A., Hundhausen C., Lambert M.H., Broadway N., Andrews R.C., Bickett D.M., et al. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 8 (2005) 161-171
54. Schulte A., Schulz B., Andrzejewski M.G., Hundhausen C., Mletzko S., Achilles J., et al. Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases. Biochem Biophys Res Commun 358 (2007) 233-240
55. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., et al. An essential role for ectodomain shedding in mammalian development. Science 282 (1998) 1281-1284
56. Gomez-Gaviro M.V., Gonzalez-Alvaro I., Dominguez-Jimenez C., Peschon J., Black R.A., Sanchez-Madrid F., et al. Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. J Biol Chem 277 (2002) 38212-38221
57. Walcheck B., Alexander S.R., St Hill C.A., and Matala E. ADAM-17-independent shedding of L-selectin. J Leukoc Biol 74 (2003) 389-394
58. Wieduwilt M.J., and Moasser M.M. The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci 65 (2008) 1566-1584
59. Uberall I., Kolar Z., Trojanec R., Berkovcova J., and Hajduch M. The status and role of ErbB receptors in human cancer. Exp Mol Pathol 84 (2008) 79-89
60. Ohtsu H., Dempsey P.J., and Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 291 (2006) C1-C10
61. Sahin U., Weskamp G., Kelly K., Zhou H.M., Higashiyama S., Peschon J., et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164 (2004) 769-779
62. Sahin U., and Blobel C.P. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. FEBS Lett 581 (2007) 41-44
63. Jackson L.F., Qiu T.H., Sunnarborg S.W., Chang A., Zhang C., Patterson C., et al. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22 (2003) 2704-2716
64. Sternlicht M.D., Sunnarborg S.W., Kouros-Mehr H., Yu Y., Lee D.C., and Werb Z. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132 (2005) 3923-3933
65. Horiuchi K., Le Gall S., Schulte M., Yamaguchi T., Reiss K., Murphy G., et al. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 18 (2007) 176-188
66. Selkoe D., and Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26 (2003) 565-597
67. Kopan R., and Ilagan M.X. Gamma-secretase: proteasome of the membrane?. Nat Rev Mol Cell Biol 5 (2004) 499-504
68. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7 (2006) 678-689
69. Kopan R., Schroeter E.H., Weintraub H., and Nye J.S. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci U S A 93 (1996) 1683-1688
70. Brou C., Logeat F., Gupta N., Bessia C., LeBail O., Doedens J.R., et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 5 (2000) 207-216
71. Mumm J.S., Schroeter E.H., Saxena M.T., Griesemer A., Tian X., Pan D.J., et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 5 (2000) 197-206
72. Lieber T., Kidd S., and Young M.W. kuzbanian-mediated cleavage of Drosophila Notch. Genes Dev 16 (2002) 209-221
73. Hartmann D., de Strooper B., Serneels L., Craessaerts K., Herreman A., Annaert W., et al. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11 (2002) 2615-2624
74. Tian L., Wu X., Chi C., Han M., Xu T., and Zhuang Y. ADAM10 is essential for proteolytic activation of Notch during thymocyte development. Int Immunol 20 (2008) 1181-1187
75. Ikeuchi T., and Sisodia S.S. The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage. J Biol Chem 278 (2003) 7751-7754
76. Six E., Ndiaye D., Laabi Y., Brou C., Gupta-Rossi N., Israel A., et al. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc Natl Acad Sci U S A 100 (2003) 7638-7643
77. Dyczynska E., Sun D., Yi H., Sehara-Fujisawa A., Blobel C.P., and Zolkiewska A. Proteolytic processing of delta-like 1 by ADAM proteases. J Biol Chem 282 (2007) 436-444
78. Furukawa K., Sopher B.L., Rydel R.E., Begley J.G., Pham D.G., Martin G.M., et al. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem 67 (1996) 1882-1896
79. Kimberly W.T., Zheng J.B., Guenette S.Y., and Selkoe D.J. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem 276 (2001) 40288-40292
80. Cao X., and Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293 (2001) 115-120
81. Gao Y., and Pimplikar S.W. The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad Sci U S A 98 (2001) 14979-14984
82. Yang Z., Cool B.H., Martin G.M., and Hu Q. A dominant role for FE65 (APBB1) in nuclear signaling. J Biol Chem 281 (2006) 4207-4214
83. Cao X., and Sudhof T.C. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem 279 (2004) 24601-24611
84. Postina R. A closer look at alpha-secretase. Curr Alzheimer Res 5 (2008) 179-186
85. Weskamp G., Cai H., Brodie T.A., Higashyama S., Manova K., Ludwig T., et al. Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol Cell Biol 22 (2002) 1537-1544
86. Goddard D.R., Bunning R.A., and Woodroofe M.N. Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia 34 (2001) 267-271
87. Marcinkiewicz M., and Seidah N.G. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J Neurochem 75 (2000) 2133-2143
88. Karkkainen I., Rybnikova E., Pelto-Huikko M., and Huovila A.P. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci 15 (2000) 547-560
89. Postina R., Schroeder A., Dewachter I., Bohl J., Schmitt U., Kojro E., et al. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113 (2004) 1456-1464
90. Kelly K., Hutchinson G., Nebenius-Oosthuizen D., Smith A.J., Bartsch J.W., Horiuchi K., et al. Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice. Dev Dyn 232 (2005) 221-231
91. Naus S., Richter M., Wildeboer D., Moss M., Schachner M., and Bartsch J.W. Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death. J Biol Chem 279 (2004) 16083-16090
92. Izumi Y., Hirata M., Hasuwa H., Iwamoto R., Umata T., Miyado K., et al. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J 17 (1998) 7260-7272
93. Koike H., Tomioka S., Sorimachi H., Saido T.C., Maruyama K., Okuyama A., et al. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem J 343 Pt 2 (1999) 371-375
94. Rooke J., Pan D., Xu T., and Rubin G.M. KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science 273 (1996) 1227-1231
95. Borneman A., Kuschel R., and Fujisawa-Sehara A. Analysis for transcript expression of meltrin alpha in normal, regenerating, and denervated rat muscle. J Muscle Res Cell Motil 21 (2000) 475-480
96. Horiuchi K., Zhou H.M., Kelly K., Manova K., and Blobel C.P. Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Dev Biol 283 (2005) 459-471
97. Masaki M., Kurisaki T., Shirakawa K., and Sehara-Fujisawa A. Role of meltrin {alpha} (ADAM12) in obesity induced by high-fat diet. Endocrinology 146 (2005) 1752-1763
98. Horiuchi K., Weskamp G., Lum L., Hammes H.P., Cai H., Brodie T.A., et al. Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol 23 (2003) 5614-5624
99. Bohm B.B., Aigner T., Roy B., Brodie T.A., Blobel C.P., and Burkhardt H. Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling. Arthritis Rheum 52 (2005) 1100-1109
100. Zhou H.M., Weskamp G., Chesneau V., Sahin U., Vortkamp A., Horiuchi K., et al. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol 24 (2004) 96-104
101. Kurohara K., Komatsu K., Kurisaki T., Masuda A., Irie N., Asano M., et al. Essential roles of Meltrin beta (ADAM19) in heart development. Dev Biol 267 (2004) 14-28
102. Sagane K., Hayakawa K., Kai J., Hirohashi T., Takahashi E., Miyamoto N., et al. Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci 6 (2005) 33
103. Fukata Y., Adesnik H., Iwanaga T., Bredt D.S., Nicoll R.A., and Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313 (2006) 1792-1795
104. Ortiz R.M., Karkkainen I., and Huovila A.P. Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells. Genes Chromosomes Cancer 41 (2004) 366-378
105. Shimizu E., Yasui A., Matsuura K., Hijiya N., Higuchi Y., and Yamamoto S. Structure and expression of the murine ADAM 15 gene and its splice variants, and difference of interaction between their cytoplasmic domains and Src family proteins. Biochem Biophys Res Commun 309 (2003) 779-785
106. Dalmay T., and Edwards D.R. MicroRNAs and the hallmarks of cancer. Oncogene 25 (2006) 6170-6175
107. Black R.A., Doedens J.R., Mahimkar R., Johnson R., Guo L., Wallace A., et al. Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity. Biochem Soc Symp (2003) 39-52
108. Amour A., Knight C.G., Webster A., Slocombe P.M., Stephens P.E., Knauper V., et al. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 473 (2000) 275-279
109. Amour A., Knight C.G., English W.R., Webster A., Slocombe P.M., Knauper V., et al. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett 524 (2002) 154-158
110. Moss M.L., and Bartsch J.W. Therapeutic benefits from targeting of ADAM family members. Biochemistry 43 (2004) 7227-7235
111. Moss M.L., Stoeck A., Yan W., and Dempsey P.J. ADAM10 as a target for anti-cancer therapy. Curr Pharm Biotechnol 9 (2008) 2-8
112. Gechtman Z., Alonso J.L., Raab G., Ingber D.E., and Klagsbrun M. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J Biol Chem 274 (1999) 28828-28835
113. Arribas J., and Borroto A. Protein ectodomain shedding. Chem Rev 102 (2002) 4627-4638
114. Schlomann U., Wildeboer D., Webster A., Antropova O., Zeuschner D., Knight C.G., et al. The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J Biol Chem 277 (2002) 48210-48219
115. Naus S., Reipschlager S., Wildeboer D., Lichtenthaler S.F., Mitterreiter S., Guan Z., et al. Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8. Biol Chem 387 (2006) 337-346
116. Fourie A.M., Coles F., Moreno V., and Karlsson L. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J Biol Chem 278 (2003) 30469-30477
117. Gomez-Gaviro M., Dominguez-Luis M., Canchado J., Calafat J., Janssen H., Lara-Pezzi E., et al. Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding. J Immunol 178 (2007) 8053-8063
118. Asai M., Hattori C., Szabo B., Sasagawa N., Maruyama K., Tanuma S., et al. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem Biophys Res Commun 301 (2003) 231-235
119. Franzke C.W., Tasanen K., Schacke H., Zhou Z., Tryggvason K., Mauch C., et al. Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J 21 (2002) 5026-5035
120. Peduto L., Reuter V.E., Shaffer D.R., Scher H.I., and Blobel C.P. Critical function for ADAM9 in mouse prostate cancer. Cancer Res 65 (2005) 9312-9319
121. Mohan S., Thompson G.R., Amaar Y.G., Hathaway G., Tschesche H., and Baylink D.J. ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 41 (2002) 15394-15403
122. Roghani M., Becherer J.D., Moss M.L., Atherton R.E., Erdjument-Bromage H., Arribas J., et al. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem 274 (1999) 3531-3540
123. Mazzocca A., Coppari R., De Franco R., Cho J.Y., Libermann T.A., Pinzani M., et al. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res 65 (2005) 4728-4738
124. Budagian V., Bulanova E., Orinska Z., Ludwig A., Rose-John S., Saftig P., et al. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17). J Biol Chem 279 (2004) 40368-40375
125. Weskamp G., Ford J.W., Sturgill J., Martin S., Docherty A.J., Swendeman S., et al. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat Immunol 7 (2006) 1293-1298
126. Eichenauer D.A., Simhadri V.L., von Strandmann E.P., Ludwig A., Matthews V., Reiners K.S., et al. ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro. Cancer Res 67 (2007) 332-338
127. Nagano O., Murakami D., Hartmann D., de Strooper B., Saftig P., Iwatsubo T., et al. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 165 (2004) 893-902
128. Vincent B., Paitel E., Saftig P., Frobert Y., Hartmann D., de Strooper B., et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 276 (2001) 37743-37746
129. Kopitz C., Gerg M., Bandapalli O.R., Ister D., Pennington C.J., Hauser S., et al. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res 67 (2007) 8615-8623
130. Millichip M.I., Dallas D.J., Wu E., Dale S., and McKie N. The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun 245 (1998) 594-598
131. Hundhausen C., Misztela D., Berkhout T.A., Broadway N., Saftig P., Reiss K., et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102 (2003) 1186-1195
132. Bech-Serra J.J., Santiago-Josefat B., Esselens C., Saftig P., Baselga J., Arribas J., et al. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol Cell Biol 26 (2006) 5086-5095
133. Liu P.C., Liu X., Li Y., Covington M., Wynn R., Huber R., et al. Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells. Cancer Biol Ther 5 (2006) 657-664
134. Schulte M., Reiss K., Lettau M., Maretzky T., Ludwig A., Hartmann D., et al. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ 14 (2007) 1040-1049
135. Matthews V., Schuster B., Schutze S., Bussmeyer I., Ludwig A., Hundhausen C., et al. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem 278 (2003) 38829-38839
136. Chen C.D., Podvin S., Gillespie E., Leeman S.E., and Abraham C.R. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A 104 (2007) 19796-19801
137. Li N., Wang Y., Forbes K., Vignali K.M., Heale B.S., Saftig P., et al. Metalloproteases regulate T-cell proliferation and effector function via LAG-3. EMBO J 26 (2007) 494-504
138. Maretzky T., Schulte M., Ludwig A., Rose-John S., Blobel C., Hartmann D., et al. L1 is sequentially processed by two differently activated metalloproteases and Presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol Cell Biol 25 (2005) 9040-9053
139. Waldhauer I., Goehlsdorf D., Gieseke F., Weinschenk T., Wittenbrink M., Ludwig A., et al. Tumor-associated MICA is shed by ADAM proteases. Cancer Res 68 (2008) 6368-6376
140. Kaczur V., Puskas L.G., Nagy Z.U., Miled N., Rebai A., Juhasz F., et al. Cleavage of the human thyrotropin receptor by ADAM10 is regulated by thyrotropin. J Mol Recognit 20 (2007) 392-404
141. Hikita A., Yana I., Wakeyama H., Nakamura M., Kadono Y., Oshima Y., et al. Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand. J Biol Chem 281 (2006) 36846-36855
142. Roy R., Wewer U.M., Zurakowski D., Pories S.E., and Moses M.A. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem 279 (2004) 51323-51330
143. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8 (2002) 35-40
144. Loechel F., Fox J.W., Murphy G., Albrechtsen R., and Wewer U.M. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 278 (2000) 511-515
145. Jacobsen J., Visse R., Sorensen H.P., Enghild J.J., Brew K., Wewer U.M., et al. Catalytic properties of ADAM12 and its domain deletion mutants. Biochemistry 47 (2008) 537-547
146. Kurisaki T., Masuda A., Sudo K., Sakagami J., Higashiyama S., Matsuda Y., et al. Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol Cell Biol 23 (2003) 55-61
147. Schafer B., Gschwind A., and Ullrich A. Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23 (2004) 991-999
148. Najy A.J., Day K.C., and Day M.L. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J Biol Chem 283 (2008) 18393-18401
149. Hart S., Fischer O.M., Prenzel N., Zwick-Wallasch E., Schneider M., Hennighausen L., et al. GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways. Biol Chem 386 (2005) 845-855
150. Lambert D.W., Yarski M., Warner F.J., Thornhill P., Parkin E.T., Smith A.I., et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280 (2005) 30113-30119
151. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., et al. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273 (1998) 27765-27767
152. Hansen H.P., Dietrich S., Kisseleva T., Mokros T., Mentlein R., Lange H.H., et al. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme. J Immunol 165 (2000) 6703-6709
153. Contin C., Pitard V., Itai T., Nagata S., Moreau J.F., and Dechanet-Merville J. Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. J Biol Chem 278 (2003) 32801-32809
154. Horiuchi K., Miyamoto T., Takaishi H., Hakozaki A., Kosaki N., Miyauchi Y., et al. Cell surface colony-stimulating factor 1 can be cleaved by TNF-alpha converting enzyme or endocytosed in a clathrin-dependent manner. J Immunol 179 (2007) 6715-6724
155. Garton K.J., Gough P.J., Blobel C.P., Murphy G., Greaves D.R., Dempsey P.J., et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276 (2001) 37993-38001
156. Rio C., Buxbaum J.D., Peschon J.J., and Corfas G. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem 275 (2000) 10379-10387
157. Zhang Y., Jiang J., Black R.A., Baumann G., and Frank S.J. Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 141 (2000) 4342-4348
158. Chalaris A., Rabe B., Paliga K., Lange H., Laskay T., Fielding C.A., et al. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110 (2007) 1748-1755
159. Kawaguchi N., Horiuchi K., Becherer J.D., Toyama Y., Besmer P., and Blobel C.P. Different ADAMs have distinct influences on Kit ligand processing: phorbol-ester-stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19. J Cell Sci 120 (2007) 943-952
160. Thathiah A., Blobel C.P., and Carson D.D. Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem 278 (2003) 3386-3394
161. Kalus I., Bormann U., Mzoughi M., Schachner M., and Kleene R. Proteolytic cleavage of the neural cell adhesion molecule by ADAM17/TACE is involved in neurite outgrowth. J Neurochem 98 (2006) 78-88
162. Fabre-Lafay S., Garrido-Urbani S., Reymond N., Goncalves A., Dubreuil P., and Lopez M. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17. J Biol Chem 280 (2005) 19543-19550
163. Cho R.W., Park J.M., Wolff S.B., Xu D., Hopf C., Kim J.A., et al. mGluR1/5-dependent long-term depression requires the regulated ectodomain cleavage of neuronal pentraxin NPR by TACE. Neuron 57 (2008) 858-871
164. Aktas B., Pozgajova M., Bergmeier W., Sunnarborg S., Offermanns S., Lee D., et al. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem 280 (2005) 39716-39722
165. Zhu L., Bergmeier W., Wu J., Jiang H., Stalker T.J., Cieslak M., et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A 104 (2007) 1621-1626
166. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (1997) 729-733
167. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Carter H.L., et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385 (1997) 733-736
168. Lum L., Wong B.R., Josien R., Becherer J.D., Erdjument-Bromage H., Schlondorff J., et al. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274 (1999) 13613-13618
169. Diaz-Rodriguez E., Montero J.C., Esparis-Ogando A., Yuste L., and Pandiella A. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell 13 (2002) 2031-2044
170. Weskamp G., Schlondorff J., Lum L., Becherer J.D., Kim T.W., Saftig P., et al. Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem 279 (2004) 4241-4249
171. Wang Y., and Sul H.S. Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiation. Mol Cell Biol 26 (2006) 5421-5435
172. Ruhe J.E., Streit S., Hart S., and Ullrich A. EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing. Cell Signal 18 (2006) 1515-1527
173. Hermey G., Sjogaard S.S., Petersen C.M., Nykjaer A., and Gliemann J. Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members. Biochem J 395 (2006) 285-293
174. Shi W., Chen H., Sun J., Buckley S., Zhao J., Anderson K.D., et al. TACE is required for fetal murine cardiac development and modeling. Dev Biol 261 (2003) 371-380
175. Zhao J., Chen H., Peschon J.J., Shi W., Zhang Y., Frank S.J., et al. Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev Biol 232 (2001) 204-218
176. Shirakabe K., Wakatsuki S., Kurisaki T., and Fujisawa-Sehara A. Roles of Meltrin beta/ADAM19 in the processing of neuregulin. J Biol Chem 276 (2001) 9352-9358
177. Chesneau V., Becherer J.D., Zheng Y., Erdjument-Bromage H., Tempst P., and Blobel C.P. Catalytic properties of ADAM19. J Biol Chem 278 (2003) 22331-22340
178. Zheng Y., Saftig P., Hartmann D., and Blobel C. Evaluation of the contribution of different ADAMs to TNFa shedding and of the function of the TNFa ectodomain in ensuring selective stimulated shedding by the TNFa convertase (TACE/ADAM17). J Biol Chem (2004)
179. Kang T., Zhao Y.G., Pei D., Sucic J.F., and Sang Q.X. Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J Biol Chem 277 (2002) 25583-25591
180. Howard L., Zheng Y., Horrocks M., Maciewicz R.A., and Blobel C. Catalytic activity of ADAM28. FEBS Lett 498 (2001) 82-86
181. Mochizuki S., Shimoda M., Shiomi T., Fujii Y., and Okada Y. ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem Biophys Res Commun 315 (2004) 79-84
182. Meng J.F., McFall C., and Rosenwasser L.J. Polymorphism R62W results in resistance of CD23 to enzymatic cleavage in cultured cells. Genes Immun 8 (2007) 215-223
183. Zou J., Zhang R., Zhu F., Liu J., Madison V., and Umland S.P. ADAM33 enzyme properties and substrate specificity. Biochemistry 44 (2005) 4247-4256
184. Chen C., Huang X., and Sheppard D. ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice. Mol Cell Biol 26 (2006) 6950-6956